The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Insulin aspart Sanofi



Sanofi Winthrop IndustrieEU/1/20/1447/001-005

Main Information

Trade NameInsulin aspart Sanofi
Active SubstancesInsulin aspart
Dosage FormSolution for injection
Licence HolderSanofi Winthrop Industrie
Licence NumberEU/1/20/1447/001-005

Group Information

ATC CodeA10AB05 insulin aspart

Status

License statusAuthorised
Licence Issued25/06/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back